Teva Pharmaceutical Industries Limited (LON:0LER)
London
· Delayed Price · Currency is GBP · Price in USD 31.09
-0.34 (-1.08%)
At close: Mar 6, 2026
LON:0LER Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | 1,410 | -1,639 | -559 | -2,446 | 417 | Upgrade
|
| Depreciation & Amortization | 1,002 | 1,059 | 1,153 | 1,308 | 1,330 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | -22 | -41 | 10 | - | Upgrade
|
| Asset Writedown & Restructuring Costs | 1,028 | 2,555 | 1,078 | 2,447 | 594 | Upgrade
|
| Loss (Gain) From Sale of Investments | - | - | - | - | 104 | Upgrade
|
| Stock-Based Compensation | 157 | 123 | 121 | 124 | 119 | Upgrade
|
| Other Operating Activities | -582 | -394 | -312 | -1,208 | -65 | Upgrade
|
| Change in Accounts Receivable | -173 | 245 | 12 | 334 | -574 | Upgrade
|
| Change in Inventory | 152 | 166 | -147 | -163 | 380 | Upgrade
|
| Change in Accounts Payable | -15 | 258 | 1,588 | 2,012 | 764 | Upgrade
|
| Change in Other Net Operating Assets | -1,330 | -1,104 | -1,525 | -828 | -2,271 | Upgrade
|
| Operating Cash Flow | 1,649 | 1,247 | 1,368 | 1,590 | 798 | Upgrade
|
| Operating Cash Flow Growth | 32.24% | -8.85% | -13.96% | 99.25% | -34.38% | Upgrade
|
| Capital Expenditures | -501 | -498 | -526 | -548 | -562 | Upgrade
|
| Cash Acquisitions | - | -15 | - | -7 | - | Upgrade
|
| Divestitures | 34 | 43 | 68 | 68 | 311 | Upgrade
|
| Investment in Securities | -15 | -31 | -46 | 3 | 125 | Upgrade
|
| Other Investing Activities | 5 | 2 | -5 | - | 1 | Upgrade
|
| Investing Cash Flow | 737 | 792 | 968 | 656 | 1,523 | Upgrade
|
| Short-Term Debt Issued | - | - | 700 | - | 700 | Upgrade
|
| Long-Term Debt Issued | 2,298 | - | 2,451 | - | 4,974 | Upgrade
|
| Total Debt Issued | 2,298 | - | 3,151 | - | 5,674 | Upgrade
|
| Short-Term Debt Repaid | - | - | -700 | - | -700 | Upgrade
|
| Long-Term Debt Repaid | -4,112 | -1,641 | -4,152 | -1,369 | -7,140 | Upgrade
|
| Total Debt Repaid | -4,112 | -1,641 | -4,852 | -1,369 | -7,840 | Upgrade
|
| Net Debt Issued (Repaid) | -1,814 | -1,641 | -1,701 | -1,369 | -2,166 | Upgrade
|
| Other Financing Activities | -337 | -150 | -212 | -118 | -6 | Upgrade
|
| Financing Cash Flow | -2,151 | -1,791 | -1,913 | -1,487 | -2,172 | Upgrade
|
| Foreign Exchange Rate Adjustments | 21 | -174 | -30 | -123 | -128 | Upgrade
|
| Net Cash Flow | 256 | 74 | 393 | 636 | 21 | Upgrade
|
| Free Cash Flow | 1,148 | 749 | 842 | 1,042 | 236 | Upgrade
|
| Free Cash Flow Growth | 53.27% | -11.04% | -19.19% | 341.52% | -63.01% | Upgrade
|
| Free Cash Flow Margin | 6.65% | 4.53% | 5.31% | 6.98% | 1.49% | Upgrade
|
| Free Cash Flow Per Share | 0.99 | 0.66 | 0.75 | 0.94 | 0.21 | Upgrade
|
| Cash Interest Paid | 950 | 1,004 | 1,078 | 948 | 913 | Upgrade
|
| Cash Income Tax Paid | 558 | 471 | 298 | 543 | 495 | Upgrade
|
| Levered Free Cash Flow | 2,032 | 2,623 | 3,298 | 2,900 | 2,307 | Upgrade
|
| Unlevered Free Cash Flow | 2,604 | 3,249 | 3,941 | 3,481 | 2,863 | Upgrade
|
| Change in Working Capital | -1,366 | -435 | -72 | 1,355 | -1,701 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.